GB1240545A - Silver-containing therapeutic agents - Google Patents

Silver-containing therapeutic agents

Info

Publication number
GB1240545A
GB1240545A GB33831/68A GB3383168A GB1240545A GB 1240545 A GB1240545 A GB 1240545A GB 33831/68 A GB33831/68 A GB 33831/68A GB 3383168 A GB3383168 A GB 3383168A GB 1240545 A GB1240545 A GB 1240545A
Authority
GB
United Kingdom
Prior art keywords
silver
july
carrier
sulphadiazine
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33831/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of GB1240545A publication Critical patent/GB1240545A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,240,545. Ointments containing silver sulphadiazine. RESEARCH CORP. 16 July, 1968 [17 July, 1967], No. 33831/68. Heading A5B. An ointment for the treatment of burns comprises silver sulphadiazine and a carrier. The carrier may be an oil-in-water emulsion or a hydrophilic ointment base. Optional ingredients are (a) silver salicylate, (b) a silver salt of an antibiotic e.g. silver penicillin, silver cephalothin, silver colistimethate or silver tetracycline, (c) another silver sulphonamide such as silver sulphamerazine, silver sulphonanilide, silver sulphamylon, silver sulphathiazole or silver sulphapyridine, (d) an aqueous solution of chloride ions e.g. NaCl. Specification 1,240,546 is referred to.
GB33831/68A 1967-07-17 1968-07-16 Silver-containing therapeutic agents Expired GB1240545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65383067A 1967-07-17 1967-07-17

Publications (1)

Publication Number Publication Date
GB1240545A true GB1240545A (en) 1971-07-28

Family

ID=24622450

Family Applications (2)

Application Number Title Priority Date Filing Date
GB33831/68A Expired GB1240545A (en) 1967-07-17 1968-07-16 Silver-containing therapeutic agents
GB4945970A Expired GB1240546A (en) 1967-07-17 1968-07-16 Improvements in or relating to antibacterial compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4945970A Expired GB1240546A (en) 1967-07-17 1968-07-16 Improvements in or relating to antibacterial compounds

Country Status (8)

Country Link
BE (1) BE718183A (en)
DE (1) DE1792053B1 (en)
ES (1) ES356142A1 (en)
FR (2) FR1586125A (en)
GB (2) GB1240545A (en)
IE (1) IE32197B1 (en)
NL (1) NL6809794A (en)
PH (1) PH10639A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291159A2 (en) * 1987-04-01 1988-11-17 Dak-Laboratoriet A/S Aminosalicylic-acid derivatives for the treatment of psoriasis
WO1992004029A1 (en) * 1990-08-29 1992-03-19 Donald Leslie Simmons Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
EP0480189A1 (en) * 1990-10-05 1992-04-15 Altergon S.A. Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances
WO2004103980A1 (en) * 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
WO2004113310A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
WO2004112782A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use v
WO2004112785A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use iii
WO2004112784A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use i
WO2004112779A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use vii
WO2004112783A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use iv
US7074788B2 (en) 2001-11-22 2006-07-11 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US7173030B2 (en) 2003-05-21 2007-02-06 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049802A (en) 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
DE2804931A1 (en) * 1978-02-06 1979-08-16 Fresenius Chem Pharm Ind METAL SULFADIAZINE IN FINE PARTICULAR FORM
US4384117A (en) * 1980-03-18 1983-05-17 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine
BRPI1104620B1 (en) * 2011-09-09 2020-04-07 Lucia Teixeira De Carvalho pharmaceutical composition for the treatment of burns and skin lesions and their preparation process

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0291159A3 (en) * 1987-04-01 1993-03-17 Dak-Laboratoriet A/S Aminosalicylic-acid derivatives for the treatment of psoriasis
EP0291159A2 (en) * 1987-04-01 1988-11-17 Dak-Laboratoriet A/S Aminosalicylic-acid derivatives for the treatment of psoriasis
WO1992004029A1 (en) * 1990-08-29 1992-03-19 Donald Leslie Simmons Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
EP0480189A1 (en) * 1990-10-05 1992-04-15 Altergon S.A. Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances
US7074788B2 (en) 2001-11-22 2006-07-11 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2004103980A1 (en) * 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
US7173030B2 (en) 2003-05-21 2007-02-06 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
WO2004112782A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use v
WO2004112784A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use i
WO2004112779A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use vii
WO2004112783A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use iv
WO2004112785A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab New use iii
WO2004113310A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing

Also Published As

Publication number Publication date
PH10639A (en) 1977-07-22
FR1586125A (en) 1970-02-13
IE32197B1 (en) 1973-05-16
GB1240546A (en) 1971-07-28
DE1792053B1 (en) 1971-07-29
NL6809794A (en) 1969-01-21
ES356142A1 (en) 1970-02-16
BE718183A (en) 1969-01-17
IE32197L (en) 1969-01-17
FR8146M (en) 1970-08-17

Similar Documents

Publication Publication Date Title
GB1240545A (en) Silver-containing therapeutic agents
GB1353837A (en) Silver zinc allantoin complex
GB1295489A (en)
GB1388178A (en) Benzylpyrimidine derivatives
GB1361198A (en) Disulphide compounds and process for their manufa'ture
CA955067A (en) Treatment of chloride solutions containing mixed metal chlorides
ES353795A1 (en) Modified Dextran and Derivatives Thereof
GB1420777A (en) Coumarin and coumarinimide compounds
GB1243401A (en) Pharmaceutical antiviral compositions
AU452927B2 (en) Production of anhydrous chloroferrate complexes from ferric chloride inan aqueous system
CA710830A (en) Disodium and calcium salt of the calcium complex of 2-aminocyclohexyl 2'-aminoethyl ether-n,n,n',n'-tetraacetic acid
CA953057A (en) Treatment of optical brightening agents
GB1175590A (en) Therapeutic Compositions
GB1388179A (en) Benzylpyrimidine derivatives
GB1249907A (en) Process for the sulphonation of a glycopeptide
GB1053177A (en)
GB1324300A (en) Antifungal thiocyanatobenzothiazoles
GB1253549A (en) Aminoguanidine derivatives
GB1107106A (en) Novel triamines
ES276824A1 (en) Procedure for the rectification of floated salinos baths (Machine-translation by Google Translate, not legally binding)
GB1239467A (en)
GB1178806A (en) Pharmaceutical Preparations containing Butenoic Acid Derivatives
CA723087A (en) Treatment of titanium bearing ores
CA762433A (en) Treatment of titanium surfaces
CA754991A (en) Potassium chloride treatment